Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v1-EN
Language English English
Date Updated 2023-08-22 2023-05-16
Drug Identification Number 02244001 02244001
Brand name ESTRADOT 75 ESTRADOT 75
Common or Proper name ESTRADOT ESTRADOT
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients ESTRADIOL ESTRADIOL
Strength(s) 75MCG 75MCG
Dosage form(s) PATCH PATCH
Route of administration TRANSDERMAL TRANSDERMAL TRANSDERMAL TRANSDERMAL
Packaging size 8TTS 8TTS
ATC code G03CA G03CA
ATC description ESTROGENS ESTROGENS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-05-15 2023-05-15
Estimated end date 2023-08-18 2023-06-09
Actual end date 2023-08-21
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments